Follow the 海泰新光 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 海泰新光 has published 43 public disclosures. Market capitalisation: €9.1bn. The latest transaction was disclosed on 28 May 2026 (Sale). Among the most active insiders: 毛荣壮. The full history is free.
43
Insider Decl.
n/a
Thresholds
€328,517
3 ops.
Buy Volume
€13m
40 ops.
Sell Volume
11Σ signal
Buys €328,517€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,810 of 28,717 companies
54.8
score / 100
Value
30
Quality
80
FCF yld1.2%
Earn yld1.5%
EV/EBITDA48.5x
ROE12%
Gross mgn66%
Net mgn28%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Haitai Xinguang is a publicly traded company on the Shanghai Stock Exchange, specializing in technology. It focuses on the development and production of innovative solutions for various markets.
